Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAMBP | O95630 | 14/20 | 0.51 |
| ▸ | PSMD14 | O00487 | 12/20 | 0.51 |
| ▸ | COPS5 | Q92905 | 10/20 | 0.51 |
| ▸ | ULK1 | O75385 | 3/20 | 0.45 |
| ▸ | HPGDS | O60760 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22455577 | 0.81 | PSMD14 (0.72) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL24093630 | 0.80 | STAMBP (0.44) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL22455566 | 0.79 | STAMBP (0.62) | STAMBPPSMD14COPS5 | |
| SCHEMBL29878838 | 0.76 | HDAC6 (0.42) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL28850620 | 0.76 | HDAC6 (0.42) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL3372289 | 0.76 | PSMD14 (0.65) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL20769426 | 0.76 | PIN1 (0.46) | STAMBPPSMD14COPS5 | |
| SCHEMBL22413921 | 0.75 | STAMBP (0.44) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL20819589 | 0.75 | STAMBP (0.44) | STAMBPPSMD14COPS5HPGDS | |
| SCHEMBL20821492 | 0.75 | PSMD14 (0.48) | STAMBPPSMD14COPS5HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11185073-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | SYNGENTA PARTICIPATIONS AG (CH) | 2021-11-30 | — | — | US | disclosed |
| US-20200170250-A1 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | SYNGENTA PARTICIPATIONS AG (CH) | 2020-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200170250-A1 | MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES | IFNG, TLR1, IDO1 | STAMBP 1536/4885PSMD14 2298/4885COPS5 1862/4885 |
| US-11185073-B2 | Microbiocidal quinoline (thio)carboxamide derivatives | IFNG, TLR1, IDO1 | STAMBP 1536/4885PSMD14 2298/4885COPS5 1862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.